Tenacibaculum maritimum can boost inflammation in Dicentrarchus labrax upon peritoneal injection but cannot trigger tenacibaculosis disease

Front Immunol. 2024 Oct 14:15:1478241. doi: 10.3389/fimmu.2024.1478241. eCollection 2024.

Abstract

Introduction: Despite being a bacterial pathogen with devastating consequences, Tenacibaculum maritimum's pathogenesis is not fully understood. The aim of the present study was to elucidate if different inoculation routes (intraperitoneal - i.p - injection and bath challenge - known to induce mortality) can induce tenacibaculosis (i.e., using the same T. maritimum inoculum), as well as evaluate the short-term immune response of European sea bass (D. labrax). Additionally, the host response against i.p. injection of extracellular products (ECPs) was also studied.

Methods: Fish were i.p. challenged with 5.5 × 105 CFU mL-1 of T. maritimum cells with or without ECPs (BECPs and BWO, respectively), ECPs alone or marine broth (mock). Another group of fish was bath-challenged with 5.5 × 105 CFU mL-1 to confirm the virulence of the bacterial inoculum. Undisturbed specimens were used as controls. The severity of both challenges was determined by following percentage survival. Blood, liver and head-kidney samples were collected at 0, 3, 6, 24 and 48 h post-challenge for assessing immune parameters, oxidative stress and gene expression. Total and differential peritoneal cell counts were performed. The presence of viable bacteria in the blood and peritoneal cavity was studied.

Results: Symptoms of tenacibaculosis, such as skin/fin abrasions, were only observed in the bath-challenged fish, where 0% survival was recorded, whereas 100% survival was observed after i.p. injection of the same bacterial inoculum. An increase in total leukocyte numbers in the peritoneal cavity was observed 3 h post-injection of BECPs when compared to the other treatments. Blood total leukocytes, lymphocytes, and thrombocyte numbers dropped after the challenge, mainly in fish challenged with BECPs. At 48 h post-challenge, bactericidal activity in the plasma increased in fish injected with bacteria (with and without ECPs). The same tendency was seen for some of the oxidative stress parameters.

Discussion/conclusions: The increased expression of il1β, il6, il8, and hamp1 in fish challenged with ECPs and BECPs suggests a more exacerbated pro-inflammatory response in the head-kidney against these inocula. The infection trial and the observed immune responses showed that the infection route is a determinant factor regarding T. maritimum-induced pathogenesis in European sea bass.

Keywords: aquaculture; gene expression; infection route; innate immunity; tenacibaculosis.

MeSH terms

  • Animals
  • Bass* / immunology
  • Bass* / microbiology
  • Cytokines / metabolism
  • Fish Diseases* / immunology
  • Fish Diseases* / microbiology
  • Flavobacteriaceae Infections* / immunology
  • Flavobacteriaceae Infections* / microbiology
  • Flavobacteriaceae Infections* / veterinary
  • Inflammation / immunology
  • Injections, Intraperitoneal
  • Tenacibaculum* / immunology

Substances

  • Cytokines

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work is supported by national funds through FCT - Fundação para a Ciência e a Tecnologia, I.P.- within the scope of UIDB/04423/2020 and UIDP/04423/2020. IF (SFRH/BD/147750/2019), PS (2022.13499.BD) and BC (2020.00290.CEECIND) benefited from FCT. AV was funded by Portuguese national funds through the FCT–Fundação para a Ciência e a Tecnologia, I.P., and, when eligible, by COMPETE 2020 FEDER funds, under the Scientific Employment Stimulus–Individual Call 2021.02251.CEECIND/CP1663/CT0016. This work had support from the Portuguese Mass Spectrometry Network, integrated into the National Roadmap of Research Infrastructures of Strategic Relevance (ROTEIRO/0028/2013; LISBOA-01-0145-FEDER-022125). This work also received funding from the European Union’s Horizon Europe research and innovation program and UK Research and Innovation under grant agreement No. 101084651 (project IGNITION).